Oragenics
OGEN
26 hedge funds and large institutions have $4.96M invested in Oragenics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
8% more funds holding
Funds holding: 24 → 26 (+2)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
27% less capital invested
Capital invested by funds: $6.82M → $4.96M (-$1.86M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBF
Sara-Bay Financial
Sarasota,
Florida
|
+$563K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$139K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$39.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$38.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$492K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$45.5K |
| 3 |
VF
Virtu Financial
New York
|
-$39.5K |
| 4 |
Jane Street
New York
|
-$12.1K |
| 5 |
HF
HRT Financial
New York
|
-$10K |
OGEN Hedge Fund Activity: Q4 2021 in Review
26 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2021, worth a combined $4.96M — down 27% from $6.82M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new OGEN positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Sara-Bay Financial, adding an estimated $563K. The largest seller was Renaissance Technologies, cutting an estimated $492K.
- 26 institutional investors held Oragenics (OGEN) as of Q4 2021, up from 24 in Q3 2021.
- Funds reported $4.96M of Oragenics stock for Q4 2021, down 27% quarter-over-quarter.
- 3 funds opened new Oragenics positions in Q4 2021 and 1 closed out, a net change of +2 holders.
- The largest Oragenics buyer in Q4 2021 was Sara-Bay Financial, an estimated $563K added.
- The largest Oragenics seller in Q4 2021 was Renaissance Technologies, an estimated $492K sold.
Based on aggregated 13F filings for Q4 2021.